The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Gastrointestinal stromal tumors - definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis
Open accessAbstract
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal (GI) tract. They are defined here as KIT (CD117, stem cell factor receptor)-positive mesenchymal spindle cell or epithelioid neoplasms primary in the GI tract, omentum, and mesentery. GISTs typically present in older individuals and are most common in the stomach (60–70%), followed by small intestine (20–25%), colon and rectum (5%), and esophagus (<5%). Benign tumors outnumber the malignant ones by a wide margin. Approximately 70% of GISTs are positive for CD34, 20–30% are positive for smooth muscle actin (SMA), 10% are positive for S100 protein and <5% are positive for desmin. The expression of CD34 and SMA is often reciprocal. GISTs commonly have activating mutations in exon 11 (or rarely exon 9 and exon 13) of the KIT gene that encodes a tyrosine kinase receptor for the growth factor named stem cell factor or mast cell growth factor. Ligand-independent activation of KIT appears to be a strong candidate for molecular pathogenesis of GISTs, and it may be a target for future treatment for such tumors. Other genetic changes in GISTs discovered using comparative genomic hybridization include losses in 14q and 22q in both benign and malignant GISTs and occurrence in various gains predominantly in malignant GISTs. GISTs have phenotypic similarities with the interstitial cells of Cajal and, therefore, a histogenetic origin from these cells has been suggested. An alternative possibility, origin of pluripotential stem cells, is also possible; this is supported by the same origin of Cajal cells and smooth muscle and by the common SMA expression in GISTs. GISTs differ clinically and pathogenetically from true leiomyosarcomas (very rare in the GI tract) and leiomyomas. The latter occur in the GI tract, predominantly in the esophagus (intramural tumors) and the colon and rectum (muscularis mucosae tumors). They also differ from schwannomas that are benign S100-positive spindle cell tumors usually presenting in the stomach. GI autonomic nerve tumors (GANTs) are probably a subset of GIST. Other mesenchymal tumors that have to be separated from GISTs include inflammatory myofibroblastic tumors in children, desmoid, and dedifferentiated liposarcoma. Angiosarcomas and metastatic melanomas, both of which are often KIT-positive, should not be confused with GISTs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,490
Kindblom, L. G., Remotti, H. E., Aldenborg, F., & Meis‐Kindblom, J. M. (1998) · Europe PMC (PubMed Central) · Cited by 1,667
Sanders, K. (1996) · Gastroenterology · doi:10.1053/gast.1996.v111.pm8690216 · Cited by 959
Gastrointestinal stromal tumors: Recent advances in understanding of their biology
Miettinen, M., Sarlomo-Rikala, M., & Lasota, J. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90040-0 · Cited by 840
Self-citationCD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34.
Sarlomo‐Rikala, M., Kovatich, A. J., Barusevicius, A., & Miettinen, M. (1998) · PubMed · Cited by 770
Self-citationRequirement of c-kit for development of intestinal pacemaker system
Maeda, H., Yamagata, A., Nishikawa, S., Yoshinaga, K., Kobayashi, S., Nishi, K., & Nishikawa, S.-I. (1992) · Development · doi:10.1242/dev.116.2.369 · Cited by 697
KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal Tumors
Lux, M. L., Rubin, B. P., Biase, T. L., Chen, C.-J., Maclure, T., Demetri, G., Xiao, S., Singer, S., Fletcher, C. D. M., & Fletcher, J. A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64946-2 · Cited by 642
Miettinen, M., Sobin, L. H., & Sarlomo-Rikala, M. (2000) · Modern Pathology · doi:10.1038/modpathol.3880210 · Cited by 626
Self-citationPrognosis of Gastrointestinal Smooth-Muscle (Stromal) Tumors: Dependence on Anatomic Site
Emory, T. S., Sobin, L. H., Lukes, L., Lee, D. H., & O'Leary, T. J. (1999) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199901000-00009 · Cited by 625
Familial gastrointestinal stromal tumours with germline mutation of the KIT gene
Nishida, T., Hirota, S., Taniguchi, M., Hashimoto, K., Isozaki, K., Nakamura, H., Kanakura, Y., Tanaka, T., Takabayashi, A., Matsuda, H., et al. (1998) · Nature Genetics · doi:10.1038/1209 · Cited by 586
Effect of c-kit Mutation on Prognosis of Gastrointestinal Stromal Tumors
谷口, 正. (2001) · Cited by 438
Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors.
Taniguchi, M., Nishida, T., Hirota, S., Isozaki, K., Ito, T., Nomura, T., Matsuda, H., & Kitamura, Y. (1999) · PubMed · Cited by 356
Torihashi*, S., Nishi‡, K., Tokutomi‡, Y., Nishi*, T., Ward§, S., & Sanders§, K. M. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70560-3 · Cited by 297
El-Rifai, W. M., Sarlomo‐Rikala, M., Andersson, L. C., Knuutila, S., & Miettinen, M. (2000) · PubMed · Cited by 245
Self-citationA novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors
Nakahara, M., Isozaki, K., Hirota, S., Miyagawa, J.-I., Hase-Sawada, N., Taniguchi, M., Nishida, T., Kanayama, S., Kitamura, Y., Shinomura, Y., et al. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70079-4 · Cited by 227
Origin of the c-kit-positive interstitial cells in the avian bowel
Lecoin, L., Gabella, G., & Douarin, N. M. L. (1996) · Development · doi:10.1242/dev.122.3.725 · Cited by 220
Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression.
Montone, K., Belle, P. A. V., Elenitsas, R., & Elder, D. (1997) · PubMed · Cited by 206
Origin of Interstitial Cells of Cajal in the Mouse Intestine
Young, H. M., Ciampoli, D., Southwell, B. R., & Newgreen, D. F. (1996) · Developmental Biology · doi:10.1006/dbio.1996.0287 · Cited by 177
Robinson, T. L., Sircar, K., Hewlett, B. R., Chorneyko, K., Riddell, R. H., & Huizinga, J. D. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64984-x · Cited by 175
Gastrointestinal Stromal Tumors
(2017) · Springer eBooks · doi:10.1007/978-3-319-42632-7 · Cited by 164
Rudolph, P., Gloeckner‐Hofmann, K., Parwaresch, R. M., Harms, D., & Schmidt, D. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90447-6 · Cited by 145
LINE-1 Elements at the Sites of Molecular Rearrangements in Alport Syndrome–Diffuse Leiomyomatosis
Segal, Y., Peissel, B., Renieri, A., Marchi, M., Ballabio, A., Pei, Y., & Zhou, J. (1999) · The American Journal of Human Genetics · doi:10.1086/302213 · Cited by 113
Novel anti-cancer agents in development: exciting prospects and new challenges
Seymour, L. (1999) · Cancer Treatment Reviews · doi:10.1053/ctrv.1999.0134 · Cited by 56
Ueki, Y., Naito, I., Oohashi, T., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301703 · Cited by 54
Workman, P., Brunton, V. G., & ROBINS, D. J. (2012) · SpringerReference · doi:10.1007/springerreference_138029 · Cited by 35
Çakar, B., & Göker, E. (2019) · Springer eBooks · doi:10.1007/978-3-030-16792-9_35 · Cited by 4
Cited by
Diagnosis of gastrointestinal stromal tumors: A consensus approach
Fletcher, C. D. M., Berman, J. J., Corless, C., Gorstein, F., Lasota, J., Longley, B. J., Miettinen, M., O'Leary, T. J., Remotti, H., Rubin, B. P., et al. (2002) · Human Pathology · doi:10.1053/hupa.2002.123545 · Cited by 3,419
Self-citationDemetri, G. D., van Oosterom, A. T., Garrett, C. R., Blackstein, M. E., Shah, M. H., Verweij, J., McArthur, G., Judson, I. R., Heinrich, M. C., Morgan, J. A., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69446-4 · Cited by 2,607
PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors
Heinrich, M. C., Corless, C. L., Duensing, A., McGreevey, L., Chen, C.-J., Joseph, N., Singer, S., Griffith, D. J., Haley, A., Town, A., et al. (2003) · Science · doi:10.1126/science.1079666 · Cited by 2,301
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
Heinrich, M. C., Corless, C. L., Demetri, G. D., Blanke, C. D., von Mehren, M., Joensuu, H., McGreevey, L. S., Chen, C.-J., Van den Abbeele, A. D., Druker, B. J., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.190 · Cited by 2,299
Nilsson, B., Bümming, P., Meis‐Kindblom, J. M., Odén, A., Dortok, A., Gustavsson, B., Sablinska, K., & Kindblom, L. (2005) · Cancer · doi:10.1002/cncr.20862 · Cited by 1,272
Metadata
- Authors
- Miettinen, M., & Lasota, J.
- Venue
- Virchows Archiv
- Published
- 2001-01-15
- Volume
- 438
- Issue
- 1
- Pages
- 1-12
- ISSN
- 0945-6317 (ISSN-L)
- 1432-2307
- OpenAlex
- W2057470956
- Cited by
- 1,854
- References
- 26
- FWCI
- 65.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.